microRNAs associated with overall survival in SCLC.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
microRNAs associated with overall survival in SCLC.
应用场景：
创建时间：
2014-03-17
相关数据集
Supplementary Material for: Lymphovascular Invasion Increases the Risk of Nodal and Distant Recurrence in Node-Negative Stage I–IIA Non-Small-Cell Lung Cancer
Objectives: Despite complete surgical resection, 30–40% of patients with stage I–IIA non-small-cell lung cancer (NSCLC) have recurrences. We aimed to elucidate the effect of lymphovascul
DataCite Commons2020-08-29 更新110
DataSheet2_Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer.PDF
Background: Lung cancer is a significant challenge to human health. Members of the high mobility group (HMG) superfamily (HMGB proteins) are implicated in a wide variety of physiological and pathophys
NIAID Data Ecosystem40
MicroRNA signature to predict the response of adjuvant chemotherapy in patients with stage II & III colorectal cancer. MicroRNA signature to predict the response of adjuvant chemotherapy in patients with stage II & III colorectal cancer
The aim of our study was to identify a microRNA signature to predict the recurrence in stage II & III CRC patients who were treated with FOLFOX-based adjuvant chemotherapy after curative resection of
NIAID Data Ecosystem30
Supplementary Material for: Post-Progression Survival Highly Influences Overall Survival in Driver Gene Mutation/Translocation Negative or Unknown Type of Non-Small Cell Lung Cancer
Introduction: In stage I–III non-small cell lung cancer (NSCLC), which is considered operable, surgical resection is the most efficacious treatment and is considered to provide a cure. However, after
NIAID Data Ecosystem50
Data_Sheet_1_A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer.pdf
Aim: Response Evaluation Criteria in Solid Tumors (RECIST) is occasionally insufficient for evaluation. We proposed a new prognostic index (NPI) that combines the standardized uptake value (SUV), meta
NIAID Data Ecosystem30
